EWTX - Edgewise Therapeutics, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Edgewise Therapeutics, Inc. Common Stock
IPO Date: March 26, 2021
Sector: Healthcare
Industry: Biotechnology
Market Cap: $4.92B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.66 | 3.69%
Avg Daily Range (30 D): $0.95 | 2.15%
Avg Daily Range (90 D): $1.29 | 3.24%
Institutional Daily Volume
Avg Daily Volume: .57M
Avg Daily Volume (30 D): .94M
Avg Daily Volume (90 D): 1.09M
Trade Size
Avg Trade Size (Sh.): 69
Avg Trade Size (Sh.) (30 D): 58
Avg Trade Size (Sh.) (90 D): 61
Institutional Trades
Total Institutional Trades: 1,923
Avg Institutional Trade: $2.23M
Avg Institutional Trade (30 D): $4.16M
Avg Institutional Trade (90 D): $3.24M
Avg Institutional Trade Volume: .09M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $3.11M
Avg Closing Trade (30 D): $8.05M
Avg Closing Trade (90 D): $7M
Avg Closing Volume: 129.18K
 
News
Sep 4, 2026 @ 7:36 PM
Will Camzyos' Long-Term Benefits Strengthen BMY's ...
Source: Na
Sep 2, 2026 @ 6:30 PM
Can CYTK's Aficamten Strengthen Its HCM Growth Pro...
Source: Na
May 6, 2026 @ 11:00 AM
Immutrin appoints leading cardiovascular drug deve...
Source: Na
Mar 17, 2026 @ 10:31 PM
Why Edgewise Therapeutics Stock Topped the Market ...
Source: Eric Volkman
Mar 17, 2026 @ 11:07 AM
The $3B Biotech With Two Shots On Goal
Source: Gav Blaxberg
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-1.86 $-.53 $-.46
Diluted EPS $-1.86 $-.53 $-.46
Revenue $M $M $M
Gross Profit
Net Income / Loss $-197.22M $-57.33M $-49.01M
Operating Income / Loss $-218.9M $-61.94M $-54.12M
Cost of Revenue
Net Cash Flow $28.92M $39.11M $-27.94M
PE Ratio